As of 2024-12-12, the Intrinsic Value of Swedish Orphan Biovitrum AB (publ) (SOBI.ST) is
176.81 SEK. This SOBI.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 317.00 SEK, the upside of Swedish Orphan Biovitrum AB (publ) is
-44.20%.
The range of the Intrinsic Value is 89.71 - 574.71 SEK
176.81 SEK
Intrinsic Value
SOBI.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
89.71 - 574.71 |
176.81 |
-44.2% |
DCF (Growth 10y) |
217.78 - 1,106.80 |
378.09 |
19.3% |
DCF (EBITDA 5y) |
306.69 - 613.73 |
482.61 |
52.2% |
DCF (EBITDA 10y) |
385.25 - 789.17 |
603.63 |
90.4% |
Fair Value |
51.15 - 51.15 |
51.15 |
-83.87% |
P/E |
135.66 - 319.14 |
228.36 |
-28.0% |
EV/EBITDA |
193.35 - 480.75 |
334.44 |
5.5% |
EPV |
95.03 - 150.83 |
122.93 |
-61.2% |
DDM - Stable |
125.54 - 626.98 |
376.26 |
18.7% |
DDM - Multi |
164.38 - 639.19 |
261.61 |
-17.5% |
SOBI.ST Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
108,869.21 |
Beta |
1.26 |
Outstanding shares (mil) |
343.44 |
Enterprise Value (mil) |
126,142.21 |
Market risk premium |
5.10% |
Cost of Equity |
6.59% |
Cost of Debt |
4.36% |
WACC |
6.09% |